CSDA 抗体 (Middle Region)
Quick Overview for CSDA 抗体 (Middle Region) (ABIN951934)
抗原
See all CSDA 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 151-181, Middle Region
- 
                                            特异性
- This antibody recognizes Human and Mouse DNA-binding protein A (Center).
- 
                                            纯化方法
- Affinity Chromatography on Protein A
- 
                                            免疫原
- KLH conjugated synthetic peptide between 151-181 amino acids from the Central region of Human CSDA. Genename: CSDA
- 
                                            亚型
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 0.25 mg/mL
- 
                                            缓冲液
- PBS, 0.09 % Sodium Azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            注意事项
- Avoid repeated freezing and thawing.
- 
                                            储存条件
- 4 °C/-20 °C
- 
                                            储存方法
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
 
- 
                                            
- 
    - 
                                            : "ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells."    in: Journal of the American Society of Nephrology : JASN, Vol. 21, Issue 3, pp. 478-88, (2010)         (PubMed).        
 : "Biochemical isolation and characterization of the tubulovesicular LC3-positive autophagosomal compartment." in: The Journal of biological chemistry, Vol. 285, Issue 2, pp. 1371-83, (2010) (PubMed).
 : "The symplekin/ZONAB complex inhibits intestinal cell differentiation by the repression of AML1/Runx1." in: Gastroenterology, Vol. 137, Issue 1, pp. 156-64, 164.e1-3, (2009) (PubMed).
 : "A dominant negative mutant of the E. coli RNA helicase DbpA blocks assembly of the 50S ribosomal subunit." in: Nucleic acids research, Vol. 37, Issue 19, pp. 6503-14, (2009) (PubMed).
 : "Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells." in: Acta pharmacologica Sinica, Vol. 30, Issue 10, pp. 1436-42, (2009) (PubMed).
 : "Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis." in: International journal of oncology, Vol. 21, Issue 4, pp. 847-50, (2002) (PubMed).
 
 
- 
                                            : "ZONAB promotes proliferation and represses differentiation of proximal tubule epithelial cells."    in: Journal of the American Society of Nephrology : JASN, Vol. 21, Issue 3, pp. 478-88, (2010)         (PubMed).        
- 
    - CSDA (Cold Shock Domain Protein A (CSDA))
- 
                                            别名
- DNA-Binding Protein A
- 
                                            背景
- CSDA binds to the GM-CSF promoter. Seems to act as a repressor. Binds also to full length mRNA and to short RNA sequences containing the consensus site 5'-UCCAUCA-3'. May have a role in translation repression (By similarity).Synonyms: CSDA, CSDA1, Cold shock domain-containing protein A, DBPA, Single-strand DNA-binding protein NF-GMB, ZONAB
- 
                                            分子量
- 40090 Da
- 
                                            基因ID
- 8531
- 
                                            NCBI登录号
- NP_001138898
- 
                                            途径
- Negative Regulation of intrinsic apoptotic Signaling
 抗原
- 
                    
 
                                     
                                     
                                    